BETH GAUS: Open Payments
NPI 1174905046 · ETNA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $321 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $104 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| ABBVIE INC. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Indivior Inc. | 1 | $28 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: Ozempic, TRELEGY ELLIPTA, QULIPTA, REXULTI, Wegovy, AUSTEDO XR, MOUNJARO, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
